ZBH

#610
Zimmer Biomet Holdings, Inc.
96.5150 USD
+1.87%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
96.4550
97.1100
Rango anual
84.5900
103.6900
Cambio diario
+1.87%
Variación mensual
+2.67%
Variación en los últimos 6 meses
-6.75%
Cambio anual
-6.75%
Cierres anteriores
94.7450
Abrir
97.0900
Bid
Ask
Mínimo
96.4550
High
97.1100
Volumen
579
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 18.8834 B
  • Employee 17 K
  • Founded N/A
  • CEO Ivan Tornos
  • Website www.zimmerbiomet.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKPL53
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
25.33
Relación precio/flujo de caja
2.25
Dividendos por acción
0.96
Rendimiento por dividendo, %
1.07

Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.

Noticias